NYSE:VAPO • US9221073052
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VAPOTHERM INC (VAPO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-11-09 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2023-02-13 | Piper Sandler | Maintains | Underweight |
| 2022-08-04 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-08-04 | BTIG | Downgrade | Buy -> Neutral |
| 2022-08-04 | Piper Sandler | Maintains | Underweight |
| 2022-06-24 | BTIG | Maintains | Buy |
| 2022-05-26 | Piper Sandler | Maintains | Underweight |
| 2022-05-06 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-05-05 | Piper Sandler | Maintains | Underweight |
| 2022-04-13 | Canaccord Genuity | Maintains | Buy |
| 2022-04-07 | Piper Sandler | Downgrade | Overweight -> Underweight |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 125.7M 161.33% | 113.3M -9.86% | 66.8M -41.04% | 71.014M 6.31% | 82.386M 16.01% | 93.978M 14.07% | 133.21M 41.75% | |
| EBITDA YoY % growth | -38.33M 15.05% | -51.15M -33.45% | -68.22M -33.37% | -30.834M 54.80% | -14.821M 51.93% | -7.341M 50.47% | N/A | |
| EBIT YoY % growth | -43.1M 10.58% | -56.8M -31.79% | -73.4M -29.23% | -41.114M 43.99% | -25.815M 37.21% | -18.937M 26.64% | -4.692M 75.22% | |
| Operating Margin | -34.29% | -50.13% | -109.88% | -57.90% | -31.33% | -20.15% | -3.52% | |
| EPS YoY % growth | -2.17 23.05% | -2.29 -5.53% | -27.76 -1,112.23% | -5.11 81.61% | -4.44 13.09% | -2.89 34.94% | -0.30 89.75% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.42 77.22% | -1.32 63.45% | -1.12 51.93% | -1.22 48.86% | -0.88 37.80% | -0.92 30.23% | -1.02 8.54% | -1.13 6.98% | -0.76 14.04% |
| Revenue Q2Q % growth | 21.124M 13.20% | 21.153M 19.31% | 19.154M 19.41% | 18.483M 21.84% | 23.63M 11.86% | 22.588M 6.78% | 20.682M 7.98% | 20.165M 9.10% | 26.226M 10.99% |
| EBITDA Q2Q % growth | -4.354M 58.88% | -4.407M 62.74% | -4M 48.11% | -4.672M 19.72% | -1.74M 60.04% | -2.096M 52.44% | -2.816M 29.60% | -3.084M 33.98% | 1.883M 208.21% |
| EBIT Q2Q % growth | -6.99M 55.68% | -7.094M 45.77% | -6.745M 33.61% | -7.44M 21.77% | -4.531M 35.18% | -6.55M 7.66% | -7.347M -8.92% | -7.692M -3.39% | -2.801M 38.18% |
All data in USD
8 analysts have analysed VAPO and the average price target is 1.02 USD. This implies a price decrease of -19.69% is expected in the next year compared to the current price of 1.27.
VAPOTHERM INC (VAPO) will report earnings on 2024-02-21, after the market close.
The consensus EPS estimate for the next earnings of VAPOTHERM INC (VAPO) is -1.42 USD and the consensus revenue estimate is 21.12M USD.
The number of analysts covering VAPOTHERM INC (VAPO) is 8.